US Foods Holding Corp.
USFDNYSECIK 1665918Consumer Defensive / Food & Staples Distributionfiscal year ends December46 quarters since 2015
Latest quarter Q2 FY2026, filed August 6, 2026. Trailing figures sum the latest four quarters. Market values at the latest close, from a market data vendor.
The last 16 quarters
Q3 FY2022 to Q2 FY2026, through the filing of August 6, 2026.
Net income losses drawn in red.
Operating cash flow less capital expenditures; negative quarters in red.
Positions at each quarter end, as filed; short-term investments are not included.
Income statement
Last eight quarters, newest first, through Q2 FY2026 filed August 6, 2026.
| Millions of dollars | Q2 FY2026ended Jun 27, 2026filed Aug 6, 2026 | Q1 FY2026ended Mar 28, 2026filed May 7, 2026 | Q4 FY2025ended Dec 27, 2025filed Feb 12, 2026 | Q3 FY2025ended Sep 27, 2025filed Nov 6, 2025 | Q2 FY2025ended Jun 28, 2025filed Aug 7, 2025 | Q1 FY2025ended Mar 29, 2025filed May 8, 2025 | Q4 FY2024ended Dec 28, 2024filed Feb 13, 2025 | Q3 FY2024ended Sep 28, 2024filed Nov 7, 2024 | YoYQ2 FY2026vs Q2 FY2025 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | 10,532 | 9,610 | 9,800 | 10,191 | 10,082 | 9,351 | 9,491 | 9,728 | +4.5% |
| Cost of revenue | 8,613 | 7,957 | 8,080 | 8,438 | 8,305 | 7,737 | 7,825 | 8,061 | +3.7% |
| Gross profit | 1,919 | 1,653 | 1,720 | 1,753 | 1,777 | 1,614 | 1,666 | 1,667 | +8.0% |
| Research and development | — | — | — | — | — | — | — | — | — |
| Selling, general and administrative | 1,477 | 1,429 | 1,386 | 1,458 | 1,403 | 1,385 | 1,362 | 1,379 | +5.3% |
| Operating income | 443 | 216 | 321 | 282 | 372 | 224 | 302 | 279 | +19.1% |
| Other income (expense) | 3 | 1 | 1 | 0 | 2 | 1 | (1) | (3) | +50.0% |
| Pretax income | 369 | 142 | 244 | 206 | 300 | 148 | 87 | 201 | +23.0% |
| Income tax | 94 | 26 | 60 | 53 | 76 | 33 | 21 | 53 | +23.7% |
| Net income | 275 | 116 | 184 | 153 | 224 | 115 | 66 | 148 | +22.8% |
| Diluted EPS ($) | 1.24 | 0.52 | — | 0.67 | 0.96 | 0.49 | — | 0.61 | +29.2% |
| Diluted shares (millions) | 221 | 223 | — | 228 | 233 | 234 | — | 244 | — |
Fourth quarters are the fiscal year less the first nine months when the filer reports no discrete fourth quarter, and are marked. Diluted EPS is never derived, so a derived quarter shows none. Italic figures are derived.
Balance sheet
Last eight quarters, newest first, through Q2 FY2026 filed August 6, 2026.
| Millions of dollars | Q2 FY2026ended Jun 27, 2026filed Aug 6, 2026 | Q1 FY2026ended Mar 28, 2026filed May 7, 2026 | Q4 FY2025ended Dec 27, 2025filed Feb 12, 2026 | Q3 FY2025ended Sep 27, 2025filed Nov 6, 2025 | Q2 FY2025ended Jun 28, 2025filed Aug 7, 2025 | Q1 FY2025ended Mar 29, 2025filed May 8, 2025 | Q4 FY2024ended Dec 28, 2024filed Feb 13, 2025 | Q3 FY2024ended Sep 28, 2024filed Nov 7, 2024 | YoYQ2 FY2026vs Q2 FY2025 |
|---|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | 56 | 49 | 41 | 56 | 61 | 101 | 59 | 81 | −8.2% |
| Short-term investments | — | — | — | — | — | — | — | — | — |
| Total current assets | 4,447 | 4,360 | 4,164 | 4,365 | 4,155 | 4,091 | 3,974 | 4,116 | +7.0% |
| Total assets | 14,336 | 14,164 | 13,943 | 14,044 | 13,790 | 13,651 | 13,436 | 13,475 | +4.0% |
| Total current liabilities | 3,911 | 3,819 | 3,591 | 3,807 | 3,559 | 3,492 | 3,296 | 3,469 | +9.9% |
| Long-term debt | — | — | — | — | — | — | — | — | — |
| Total liabilities | 10,057 | 9,831 | 9,636 | 9,573 | 9,164 | 9,035 | 8,908 | 8,869 | +9.7% |
| Stockholders’ equity | 4,279 | 4,333 | 4,307 | 4,471 | 4,626 | 4,616 | 4,528 | 4,606 | −7.5% |
| Shares outstanding (millions) | 216 | 220 | 221 | 223 | 225 | 231 | 230 | 233 | — |
Positions at each period end. Nothing on this statement is derived. Long-term debt is the filed noncurrent line only; no total-debt composite is constructed across filers. Italic figures are derived.
Cash flow statement
Last eight quarters, newest first, through Q2 FY2026 filed August 6, 2026.
| Millions of dollars | Q2 FY2026ended Jun 27, 2026filed Aug 6, 2026 | Q1 FY2026ended Mar 28, 2026filed May 7, 2026 | Q4 FY2025ended Dec 27, 2025filed Feb 12, 2026 | Q3 FY2025ended Sep 27, 2025filed Nov 6, 2025 | Q2 FY2025ended Jun 28, 2025filed Aug 7, 2025 | Q1 FY2025ended Mar 29, 2025filed May 8, 2025 | Q4 FY2024ended Dec 28, 2024filed Feb 13, 2025 | Q3 FY2024ended Sep 28, 2024filed Nov 7, 2024 | YoYQ2 FY2026vs Q2 FY2025 |
|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | 431 | 294 | 293 | 351 | 334 | 391 | 283 | 270 | +29.0% |
| Capital expenditures | 76 | 98 | 134 | 115 | 77 | 84 | 105 | 80 | −1.3% |
| Free cash flow (CFO − capex) | 355 | 196 | 159 | 236 | 257 | 307 | 178 | 190 | +38.1% |
| Depreciation and amortization | 118 | 119 | 117 | 118 | 115 | 112 | 111 | 114 | +2.6% |
| Share repurchases | 370 | 75 | 324 | 332 | 247 | 23 | 320 | 574 | +49.8% |
| Dividends paid | — | — | — | — | — | — | — | — | — |
10-Qs file cash flows as year-to-date totals, so quarterly figures are differenced from consecutive filings and marked. Free cash flow is operating cash flow less capital expenditures, computed from the two filed lines. Italic figures are derived.
Annual statements
Every fiscal year filed, newest first, through FY2025 filed February 12, 2026.
Income statement
| Millions of dollars | FY2025ended Dec 27, 2025filed Feb 12, 2026 | FY2024ended Dec 28, 2024filed Feb 13, 2025 | FY2023ended Dec 30, 2023filed Feb 15, 2024 | FY2022ended Dec 31, 2022filed Feb 17, 2023 | FY2021ended Jan 1, 2022filed Feb 17, 2022 | FY2020ended Jan 2, 2021filed Feb 16, 2021 | FY2019ended Dec 28, 2019filed Feb 13, 2020 | FY2018ended Dec 29, 2018filed Feb 14, 2019 | FY2017ended Dec 30, 2017filed Feb 27, 2018 | FY2016ended Dec 31, 2016filed Feb 28, 2017 | FY2015ended Jan 2, 2016filed Aug 9, 2016 | FY2014ended Dec 27, 2014filed Aug 9, 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 39,424 | 37,877 | 35,597 | 34,057 | 29,487 | 22,885 | 25,939 | 24,175 | 24,147 | 22,919 | 23,128 | 23,020 |
| Cost of revenue | 32,560 | 31,343 | 29,449 | 28,565 | 24,832 | 19,166 | 21,352 | 19,869 | 19,929 | 18,866 | — | — |
| Gross profit | 6,864 | 6,534 | 6,148 | 5,492 | 4,655 | 3,719 | 4,587 | 4,306 | 4,218 | 4,053 | 4,013 | 3,798 |
| Research and development | — | — | — | — | — | — | — | — | — | — | — | — |
| Selling, general and administrative | 5,632 | 5,412 | 5,117 | 4,886 | 4,220 | 3,757 | 3,888 | 3,647 | 3,631 | 3,581 | 3,651 | 3,545 |
| Operating income | 1,199 | 1,099 | 1,017 | 594 | 424 | (77) | 699 | 658 | 588 | 419 | 190 | 252 |
| Other income (expense) | 4 | (6) | 6 | 22 | 26 | 21 | (4) | 13 | (14) | (5) | — | — |
| Pretax income | 898 | 644 | 678 | 361 | 214 | (294) | 511 | 496 | 404 | 131 | 192 | (37) |
| Income tax | 222 | 150 | 172 | 96 | 50 | (68) | 126 | 89 | (40) | (79) | 25 | 36 |
| Net income | 676 | 494 | 506 | 265 | 164 | (226) | 385 | 407 | 444 | 210 | 168 | (73) |
| Diluted EPS ($) | 2.94 | 2.02 | 2.02 | 1.01 | 0.54 | (1.15) | 1.75 | 1.87 | 1.97 | 1.03 | 0.98 | (0.43) |
| Diluted shares (millions) | 230 | 244 | 250 | 226 | 225 | 220 | 220 | 218 | 226 | 204 | 171 | 169 |
Balance sheet
| Millions of dollars | FY2025ended Dec 27, 2025filed Feb 12, 2026 | FY2024ended Dec 28, 2024filed Feb 13, 2025 | FY2023ended Dec 30, 2023filed Feb 15, 2024 | FY2022ended Dec 31, 2022filed Feb 17, 2023 | FY2021ended Jan 1, 2022filed Feb 17, 2022 | FY2020ended Jan 2, 2021filed Feb 16, 2021 | FY2019ended Dec 28, 2019filed Feb 13, 2020 | FY2018ended Dec 29, 2018filed Feb 14, 2019 | FY2017ended Dec 30, 2017filed Feb 27, 2018 | FY2016ended Dec 31, 2016filed Feb 28, 2017 | FY2015ended Jan 2, 2016filed Aug 9, 2016 | FY2014ended Dec 27, 2014filed Aug 9, 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | 41 | 59 | 269 | 211 | 148 | 828 | 90 | 104 | 119 | 131 | 518 | 344 |
| Short-term investments | — | — | — | — | — | — | — | — | — | — | — | — |
| Total current assets | 4,164 | 3,974 | 4,031 | 3,820 | 3,594 | 3,465 | 3,262 | 2,979 | 2,819 | 2,789 | 3,060 | — |
| Total assets | 13,943 | 13,436 | 13,187 | 12,773 | 12,521 | 12,423 | 11,288 | 9,186 | 9,037 | 8,944 | 9,239 | — |
| Total current liabilities | 3,591 | 3,296 | 3,112 | 2,796 | 2,550 | 1,982 | 2,362 | 2,076 | 2,003 | 1,969 | 1,803 | — |
| Long-term debt | — | — | — | 0 | — | — | — | — | 3,800 | 3,800 | 4,682 | — |
| Total liabilities | 9,636 | 8,908 | 8,438 | 8,278 | 8,252 | 8,374 | 7,579 | 5,957 | 6,286 | 6,407 | 7,328 | — |
| Stockholders’ equity | 4,307 | 4,528 | 4,749 | 3,961 | 3,735 | 3,530 | 3,709 | 3,229 | 2,751 | 2,538 | 1,873 | 1,622 |
| Shares outstanding (millions) | 221 | 230 | 245 | 224 | 223 | 221 | 220 | 218 | 215 | 221 | — | — |
Cash flow statement
| Millions of dollars | FY2025ended Dec 27, 2025filed Feb 12, 2026 | FY2024ended Dec 28, 2024filed Feb 13, 2025 | FY2023ended Dec 30, 2023filed Feb 15, 2024 | FY2022ended Dec 31, 2022filed Feb 17, 2023 | FY2021ended Jan 1, 2022filed Feb 17, 2022 | FY2020ended Jan 2, 2021filed Feb 16, 2021 | FY2019ended Dec 28, 2019filed Feb 13, 2020 | FY2018ended Dec 29, 2018filed Feb 14, 2019 | FY2017ended Dec 30, 2017filed Feb 27, 2018 | FY2016ended Dec 31, 2016filed Feb 28, 2017 | FY2015ended Jan 2, 2016filed Aug 9, 2016 | FY2014ended Dec 27, 2014filed Aug 9, 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | 1,369 | 1,174 | 1,140 | 765 | 419 | 413 | 760 | 609 | 749 | 549 | — | — |
| Capital expenditures | 410 | 341 | 309 | 265 | 274 | 189 | 258 | 235 | 221 | 164 | 187 | 147 |
| Free cash flow (CFO − capex) | 959 | 833 | 831 | 500 | 145 | 224 | 502 | 374 | 528 | 385 | — | — |
| Depreciation and amortization | 462 | 438 | 395 | 372 | 378 | 422 | 362 | 340 | 378 | 421 | 399 | 412 |
| Share repurchases | 926 | 948 | 294 | 14 | 0 | 0 | 0 | 0 | 280 | 0 | — | — |
| Dividends paid | — | — | — | — | — | — | — | — | — | — | — | — |
Insider activity
Form 4 filings by officers, directors and 10% owners, November 1, 2024 to November 1, 2026. Only open-market purchases and sales count as buys and sells; awards, exercises, tax withholding and gifts are listed in grey and never counted.
The last 25 transactions
| Traded | Insider | Role | Transaction | Shares | Price | Value | Held after | Filed |
|---|---|---|---|---|---|---|---|---|
| Aug 14, 2026 | Flitman David E | See remarks, Director | gift | 29,000 | $0.00 | — | 468,587 | Aug 17, 2026 |
| Aug 14, 2026 | Flitman David E | See remarks, Director | giftindirect | 29,000 | $0.00 | — | 29,000 | Aug 17, 2026 |
| Aug 14, 2026 | Flitman David E | See remarks, Director | gift | 130,000 | $0.00 | — | 338,587 | Aug 17, 2026 |
| Aug 14, 2026 | Flitman David E | See remarks, Director | giftindirect | 130,000 | $0.00 | — | 130,000 | Aug 17, 2026 |
| Aug 13, 2026 | Taylor Randy J | See Remarks | option exercise | 6,431 | $33.56 | $216K | 80,049 | Aug 14, 2026 |
| Aug 13, 2026 | Taylor Randy J | See Remarks | open-market sale | 6,431 | $110.40 | $710K | 73,618 | Aug 14, 2026 |
| Aug 13, 2026 | Taylor Randy J | See Remarks | option exercise | 5,199 | $34.56 | $180K | 78,817 | Aug 14, 2026 |
| Aug 13, 2026 | Taylor Randy J | See Remarks | open-market sale | 5,199 | $110.34 | $574K | 73,618 | Aug 14, 2026 |
| Aug 7, 2026 | Hancock William Spencer | See Remarks | open-market sale | 21,754 | $108.29 | $2M | 101,144 | Aug 11, 2026 |
| Jun 5, 2026 | Taylor Randy J | See Remarks | tax withholding | 1,271 | $84.61 | $108K | 73,618 | Jun 8, 2026 |
| May 19, 2026 | Tehle David M | Director | option exercise | 406 | $23.50 | $10K | 39,627 | May 21, 2026 |
| May 19, 2026 | Tehle David M | Director | tax withholding | 117 | $81.87 | $10K | 39,510 | May 21, 2026 |
| May 19, 2026 | Tehle David M | Director | option exercise | 406 | $23.50 | $10K | 39,916 | May 21, 2026 |
| May 19, 2026 | Tehle David M | Director | tax withholding | 117 | $81.87 | $10K | 39,799 | May 21, 2026 |
| May 19, 2026 | Tehle David M | Director | option exercise | 1,624 | $23.50 | $38K | 41,423 | May 21, 2026 |
| May 19, 2026 | Tehle David M | Director | tax withholding | 467 | $81.74 | $38K | 40,956 | May 21, 2026 |
| May 14, 2026 | Ziegler Ann Elizabeth | Director | award | 2,204 | $0.00 | — | 32,220 | May 18, 2026 |
| May 14, 2026 | Roach Quentin | Director | award | 2,204 | $0.00 | — | 16,482 | May 18, 2026 |
| May 14, 2026 | Tehle David M | Director | award | 2,204 | $0.00 | — | 39,221 | May 18, 2026 |
| May 14, 2026 | Pforzheimer Carl Andrew | Director | award | 2,204 | $0.00 | — | 43,423 | May 18, 2026 |
| May 14, 2026 | Gottschalk Marla C | Director | award | 2,204 | $0.00 | — | 16,482 | May 18, 2026 |
| May 14, 2026 | Bullock David W | Director | award | 2,204 | $0.00 | — | 9,010 | May 18, 2026 |
| May 14, 2026 | Bachelder Cheryl A | Director | award | 2,204 | $0.00 | — | 35,349 | May 18, 2026 |
| Mar 30, 2026 | Locascio Dirk J. | EVP, Chief Financial Officer | otherindirect | 42,732 | $0.00 | — | 62,732 | Mar 31, 2026 |
| Mar 30, 2026 | Locascio Dirk J. | EVP, Chief Financial Officer | gift | 85,464 | $0.00 | — | 20,798 | Mar 31, 2026 |
Full insider history for US Foods Holding Corp., or insider activity across all companies. A record of filings, not a recommendation.
Tracked funds holding it
1 of the tracked managers held USFD in their latest 13F filing, through August 14, 2026. Weight is the share of the fund’s reported portfolio. How the funds have traded USFD by quarter.
| Fund | Manager | Quarter | Value | Shares | Weight | Move |
|---|---|---|---|---|---|---|
| Lone Pine Capital | Steve Mandel | Q2 2026 | $503M | 5M | 3.07% | added +29.5% |
Sources
Fiscal year ends in month 12; periods are labeled with the issuer's own fiscal calendar. Values are as most recently filed (restatements apply; per-share values are on current split basis per the connector's split table, flagged in adjusted). Flow items flagged in `derived` were computed (Q4 = FY − nine months; quarterly cash flow differenced from year-to-date filings) rather than read from a filing. `reconciliation.repaired` lists periods where a full-year figure was filed in a quarter slot: that row was dropped and the quarter rebuilt from the annual figure. `reconciliation.quarantined` lists periods where four filed quarters do not sum to the filed year — those quarterly values are withheld, so a blank there is a withholding rather than an absence of reporting.
- Filer
- US FOODS HOLDING CORP., CIK 1665918 on EDGAR
- Extract generated
- November 1, 2026
- Withheld
- none
- Repaired
- none
XBRL concepts behind each line
Income statement
RevenueFromContractWithCustomerExcludingAssessedTax, SalesRevenueNetCostOfGoodsAndServicesSoldGrossProfitSellingGeneralAndAdministrativeExpenseOperatingIncomeLossOtherNonoperatingIncomeExpenseIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterestIncomeTaxExpenseBenefitNetIncomeLossEarningsPerShareDilutedWeightedAverageNumberOfDilutedSharesOutstandingBalance sheet
CashAndCashEquivalentsAtCarryingValueAssetsCurrentAssetsLiabilitiesCurrentLongTermDebt, LongTermDebtNoncurrentLiabilitiesStockholdersEquitydei:EntityCommonStockSharesOutstandingCash flow statement
NetCashProvidedByUsedInOperatingActivitiesPaymentsToAcquirePropertyPlantAndEquipmentDepreciationAndAmortization, DepreciationDepletionAndAmortizationPaymentsForRepurchaseOfCommonStockThe data
The statements on this page as files, generated November 1, 2026.
- JSON file
/data/financials/USFD.json